Affimed GmbH – Trademark Portfolio
Entity Type: 99
Affimed GmbH holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include ICE and AFFIMED. The owner is based in Mannheim.
Gottlieb-Daimler StraÃe 2
Mannheim 68165 , DE
Showing of trademarks Trademarks
Trademark Classifications
Affimed GmbH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Affimed GmbH have?
Affimed GmbH has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does Affimed GmbH file in?
Affimed GmbH files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Affimed GmbH's most well-known trademarks?
Affimed GmbH's registered trademark portfolio includes well-known marks such as ICE and AFFIMED. These are among 4 currently registered trademarks in the portfolio.
What is Affimed GmbH's trademark registration success rate?
Affimed GmbH has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.